| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4234252
[patent_doc_number] => 06165786
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Antisense modulation of nucleolin expression'
[patent_app_type] => 1
[patent_app_number] => 9/433699
[patent_app_country] => US
[patent_app_date] => 1999-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28758
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/165/06165786.pdf
[firstpage_image] =>[orig_patent_app_number] => 433699
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/433699 | Antisense modulation of nucleolin expression | Nov 2, 1999 | Issued |
Array
(
[id] => 880484
[patent_doc_number] => 07355016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-08
[patent_title] => 'Methods for detection of mycobacteria'
[patent_app_type] => utility
[patent_app_number] => 09/432820
[patent_app_country] => US
[patent_app_date] => 1999-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 8829
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/355/07355016.pdf
[firstpage_image] =>[orig_patent_app_number] => 09432820
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/432820 | Methods for detection of mycobacteria | Nov 1, 1999 | Issued |
Array
(
[id] => 803199
[patent_doc_number] => 07422902
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-09-09
[patent_title] => 'Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer'
[patent_app_type] => utility
[patent_app_number] => 09/431594
[patent_app_country] => US
[patent_app_date] => 1999-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 68
[patent_no_of_words] => 28201
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/422/07422902.pdf
[firstpage_image] =>[orig_patent_app_number] => 09431594
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/431594 | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer | Oct 31, 1999 | Issued |
Array
(
[id] => 6801171
[patent_doc_number] => 20030096336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'INSECT SODIUM CHANNELS FROM INSECTICIDE-SUSCEPTIBLE AND INSECTICIDE-RESISTANT HOUSE FLIES'
[patent_app_type] => new
[patent_app_number] => 09/428371
[patent_app_country] => US
[patent_app_date] => 1999-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11542
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096336.pdf
[firstpage_image] =>[orig_patent_app_number] => 09428371
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/428371 | Insect sodium channels from insecticide-susceptible and insecticide-resistant house flies | Oct 27, 1999 | Issued |
Array
(
[id] => 4305013
[patent_doc_number] => 06315978
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Bioconjugates and delivery of bioactive agents'
[patent_app_type] => 1
[patent_app_number] => 9/202328
[patent_app_country] => US
[patent_app_date] => 1999-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 21448
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/315/06315978.pdf
[firstpage_image] =>[orig_patent_app_number] => 202328
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/202328 | Bioconjugates and delivery of bioactive agents | Oct 21, 1999 | Issued |
| 09/403539 | OLIGONUCLEOTIDES FOR ENHANCED BIOAVAILABILITY | Oct 21, 1999 | Abandoned |
Array
(
[id] => 1485613
[patent_doc_number] => 06365577
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'p53 antisense agent and method'
[patent_app_type] => B1
[patent_app_number] => 09/426804
[patent_app_country] => US
[patent_app_date] => 1999-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8223
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365577.pdf
[firstpage_image] =>[orig_patent_app_number] => 09426804
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/426804 | p53 antisense agent and method | Oct 21, 1999 | Issued |
Array
(
[id] => 958837
[patent_doc_number] => 06953783
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-10-11
[patent_title] => 'Modulation of gene expression by combination therapy'
[patent_app_type] => utility
[patent_app_number] => 09/420692
[patent_app_country] => US
[patent_app_date] => 1999-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 20769
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/953/06953783.pdf
[firstpage_image] =>[orig_patent_app_number] => 09420692
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/420692 | Modulation of gene expression by combination therapy | Oct 18, 1999 | Issued |
Array
(
[id] => 1047007
[patent_doc_number] => 06864403
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-08
[patent_title] => 'Plant protein disulfide isomerases'
[patent_app_type] => utility
[patent_app_number] => 09/417251
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11971
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/864/06864403.pdf
[firstpage_image] =>[orig_patent_app_number] => 09417251
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/417251 | Plant protein disulfide isomerases | Oct 12, 1999 | Issued |
Array
(
[id] => 1247903
[patent_doc_number] => 06673537
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-06
[patent_title] => 'Promoters from chlorella virus genes providing for expression of genes in prokaryotic and eukaryotic hosts'
[patent_app_type] => B1
[patent_app_number] => 09/416548
[patent_app_country] => US
[patent_app_date] => 1999-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 13375
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673537.pdf
[firstpage_image] =>[orig_patent_app_number] => 09416548
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416548 | Promoters from chlorella virus genes providing for expression of genes in prokaryotic and eukaryotic hosts | Oct 11, 1999 | Issued |
| 09/319395 | TISSUE SPECIFIC AND TARGET RNA-SPECIFIC RIBOZYMES AS ANTIMICROBIAL THERAPEUTICS AGAINST MICROBIAL PATHOGENS | Oct 4, 1999 | Abandoned |
Array
(
[id] => 7640023
[patent_doc_number] => 06395892
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-28
[patent_title] => 'Floral homeotic genes for manipulation of flowering in poplar and other plant species'
[patent_app_type] => B1
[patent_app_number] => 09/410464
[patent_app_country] => US
[patent_app_date] => 1999-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16476
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/395/06395892.pdf
[firstpage_image] =>[orig_patent_app_number] => 09410464
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/410464 | Floral homeotic genes for manipulation of flowering in poplar and other plant species | Sep 30, 1999 | Issued |
Array
(
[id] => 4347023
[patent_doc_number] => 06214621
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing them'
[patent_app_type] => 1
[patent_app_number] => 9/331912
[patent_app_country] => US
[patent_app_date] => 1999-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9614
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214621.pdf
[firstpage_image] =>[orig_patent_app_number] => 331912
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/331912 | Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing them | Sep 29, 1999 | Issued |
Array
(
[id] => 1308465
[patent_doc_number] => 06617442
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-09
[patent_title] => 'Human Rnase H1 and oligonucleotide compositions thereof'
[patent_app_type] => B1
[patent_app_number] => 09/409926
[patent_app_country] => US
[patent_app_date] => 1999-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 43515
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/617/06617442.pdf
[firstpage_image] =>[orig_patent_app_number] => 09409926
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/409926 | Human Rnase H1 and oligonucleotide compositions thereof | Sep 29, 1999 | Issued |
Array
(
[id] => 1346622
[patent_doc_number] => 06579716
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-17
[patent_title] => 'Better emergence characteristics and improved seedling growth under low-light environments'
[patent_app_type] => B1
[patent_app_number] => 09/407956
[patent_app_country] => US
[patent_app_date] => 1999-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 30
[patent_no_of_words] => 25411
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/579/06579716.pdf
[firstpage_image] =>[orig_patent_app_number] => 09407956
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/407956 | Better emergence characteristics and improved seedling growth under low-light environments | Sep 27, 1999 | Issued |
| 09/269035 | ANTISENSE GENE THERAPY FOR RNA VIRUSES | Sep 26, 1999 | Abandoned |
| 09/404053 | Xrcc3 is required for assembly of rad51-complexes in vivo | Sep 21, 1999 | Abandoned |
Array
(
[id] => 4406140
[patent_doc_number] => 06271200
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles'
[patent_app_type] => 1
[patent_app_number] => 9/397701
[patent_app_country] => US
[patent_app_date] => 1999-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5022
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 277
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/271/06271200.pdf
[firstpage_image] =>[orig_patent_app_number] => 397701
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/397701 | Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles | Sep 15, 1999 | Issued |
| 09/395401 | PLANT RESISTANCE TO INSECT PESTS MEDIATED BY VIRAL PROTEINS | Sep 13, 1999 | Abandoned |
| 09/397711 | Antisense compounds which prevent cell death and uses thereof | Sep 2, 1999 | Abandoned |